Johnson & Johnson is yet again making headlines after the pharmaceutical company was granted FDA approval for their new booster shot.
Johnson & Johnson boasted about its lack of safety, citing “We out did ourselves with this one. Our new booster shot is now 79% more likely to cause blood clots, as to our previous jab which only had a roughly 32.5% chance at giving one a blood clot.”
Johnson & Johnson shares soared on the good news.
